Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
ACADIA Pharmaceuticals (ACAD)
NASDAQ:ACAD
ACADIA Pharmaceuticals (ACAD) Stock Forecast & Price Target
2,190 Followers
See the Price Targets and Ratings of:
ACAD Analyst Ratings
Moderate Buy
10 Buy
4 Hold
0 Sell
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months
ACAD Stock 12 Month Forecast
Average Price Target
$27.36
▲(69.62% Upside)
| Highest Price Target$39.00 | Average Price Target$27.36 | Lowest Price Target$17.00 |
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.
Detailed List of Analyst Forecasts
Stifel Nicolaus
Reiterated
05/10/24
H.C. Wainwright
Reiterated
05/09/24
Bank of America Securities
Reiterated
05/09/24
Canaccord Genuity
Reiterated
05/09/24
JMP Securities
Reiterated
05/09/24
Robert W. Baird
Assigned
05/08/24
Leerink Partners
$33→$28
Buy
73.59%
Upside
Reiterated
05/08/24
Buy Rating for ACADIA Pharmaceuticals Based on Promising Drug Prospects and Financial Stability
Citi
$30.19→$30
Buy
85.99%
Upside
Reiterated
05/08/24
Acadia Pharmaceuticals price target lowered to $30 from $30.19 at CitiAcadia Pharmaceuticals price target lowered to $30 from $30.19 at Citi
Mizuho Securities
$25→$21
Hold
30.19%
Upside
Reiterated
05/08/24
Acadia Pharmaceuticals price target lowered to $21 from $25 at MizuhoAcadia Pharmaceuticals price target lowered to $21 from $25 at Mizuho
UBS
$33→$27
Buy
67.39%
Upside
Reiterated
04/30/24
Acadia Pharmaceuticals (ACAD) PT Lowered to $27 at UBSUBS analyst Ashwani Verma lowered the price target on Acadia Pharmaceuticals (NASDAQ: ACAD) to $27.00 (from $33.00) while maintaining a Buy rating.
J.P. Morgan
$29→$25
Buy
54.99%
Upside
Reiterated
03/25/24
Acadia Pharmaceuticals price target lowered to $25 from $29 at JPMorganAcadia Pharmaceuticals price target lowered to $25 from $29 at JPMorgan
Best Analysts Covering ACADIA Pharmaceuticals
Which Analyst Should I Follow If I Want to Buy ACAD and Sell After:
1 Month
3 Months
1 Year
Success Rate
14/23 ratings generated profit
Average Return
+9.27%
reiterated a buy rating 4 months ago
Copying Ritu Baral's trades and holding each position for 1 Year would result in 60.87% of your transactions generating a profit, with an average return of +9.27% per trade.
2 Years
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.
ACAD Analyst Recommendation Trends
Rating
Feb 24
Mar 24
Apr 24
May 24
Jun 24
Strong Buy
12
19
22
19
13
Buy
19
17
11
6
0
Hold
9
8
8
9
5
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
40
44
41
34
18
Each month's total comprises the sum of three months' worth of ratings.
xxxxxxxxxxxxxxx
xxxxxxxxxxxxxxx
xxxxxxxxxxxxxxx
xxxxxxxxxxxxxxx
xxxxxxxxxxxxxxx
ACAD Financial Forecast
ACAD Stock Forecast FAQ
What is ACAD’s average 12-month price target, according to analysts?
Based on analyst ratings, ACADIA Pharmaceuticals’s 12-month average price target is $27.36.
What is ACAD’s upside potential, based on the analysts’ average price target?
ACADIA Pharmaceuticals has 69.62% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is ACAD a Buy, Sell or Hold?
ACADIA Pharmaceuticals has a consensus rating of Moderate Buy which is based on 10 buy ratings, 4 hold ratings and 0 sell ratings.
What is ACADIA Pharmaceuticals’s price target?
The average price target for ACADIA Pharmaceuticals is $27.36. This is based on 14 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst price target is $39.00 ,the lowest forecast is $17.00. The average price target represents 69.62% Increase from the current price of $16.13.
The highest analyst price target is $39.00 ,the lowest forecast is $17.00. The average price target represents 69.62% Increase from the current price of $16.13.
What do analysts say about ACADIA Pharmaceuticals?
ACADIA Pharmaceuticals’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 14 Wall Streets Analysts.
How can I buy shares of ACAD?
Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.